Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
11.70
-1.61 (-12.07%)
At close: Mar 9, 2026, 4:00 PM EDT
11.70
0.00 (0.04%)
After-hours: Mar 9, 2026, 4:30 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.50 billion as of March 9, 2026. Its market cap has increased by 249.61% in one year.
Market Cap
1.50B
Enterprise Value
1.33B
1-Year Change
249.61%
Ranking
Category
Stock Price
$11.70
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.50B, an increase of 1,664.52%. That is a compound annual growth rate of 52.19%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.61B |
| Harmony Biosciences Holdings | 1.61B |
| Oruka Therapeutics | 1.60B |
| Oculis Holding AG | 1.59B |
| Nurix Therapeutics | 1.58B |
| Vir Biotechnology | 1.54B |
| Capricor Therapeutics | 1.54B |
| Generate Biomedicines | 1.53B |